Care Path for Poland. Explore public care and possible funding before comparing private providers. Your clinician and payer decide suitability and eligibility.
Your public health system
Start with your usual doctor or public insurer to discuss a referral for this treatment.
Who can use it: Check eligibility and treatment coverage with your public insurer; residence alone does not establish entitlement.
Cost to you: varies — Confirm a written patient price or funding decision.
Reported public wait: 37 days — median of reported average waiting time; 247 providers, patients who were treated
Source: NFZ · Source period: September 2026 · Captured: 2026-10-14 · n=253 observationsWhat this figure covers
Scope: Poland. Population: patients who were treated. Reported statistic: average waiting time. Unweighted median of provider statistics; sites per provider are consolidated first. This is not a patient-level national average or median.
n=253 eligible observations; 247 providers. n is not a patient count. Episode equivalence: unverified.
Routine NFZ benefit cohort; revisions, technique and episode inclusions are not isolated. Provider-reported mean for patients removed after treatment; excludes current waiting-list age and first available date.
Additional source pages: 2, 3, 4, 5, 6, 7, 8, 9, 10, 11
Methodology and exclusions
- Ask your doctor whether this treatment is appropriate.
- Confirm coverage, referral requirements and the current waiting list with your insurer or hospital.
Public care information · Guidance reviewed: 2026-10-15
EU cross-border reimbursement · Directive 2011/24/EU
You usually pay first and request reimbursement up to the home-country public tariff, capped at the actual eligible cost. Prior authorisation may be needed, including for some hospital care.
Who can use it: Check eligibility, covered treatment, authorisation and the reimbursable amount with your home insurer and National Contact Point before booking.
Cost to you: varies — Confirm a written patient price or funding decision.
Reported public wait: No official figure available for this route.
- Contact your home-country National Contact Point.
- Get any required prior authorisation and a written reimbursement estimate.
- Keep itemised invoices and medical records to submit to your home insurer.
Directive 2011/24/EU · Articles 7–8 · Guidance reviewed: 2026-10-15
PL National Contact Point · choose your country · Guidance reviewed: 2026-10-15
Public treatment abroad · S2 form
A separate route for authorised treatment in another participating public health system, under that system’s payment rules. Patient co-payments may remain.
Who can use it: Check eligibility with your home public insurer. Obtain prior authorisation and confirm that the treating institution accepts S2.
Cost to you: varies — Confirm a written patient price or funding decision.
Reported public wait: No official figure available for this route.
- Ask your home public insurer to assess an S2 application.
- Confirm the hospital, treatment, covered dates and patient charges.
- Receive the S2 form before travelling and arrange it with the receiving institution.
Official S2 guidance · Guidance reviewed: 2026-10-15
PL National Contact Point · choose your country · Guidance reviewed: 2026-10-15
Private care near home
Ask local providers for a written quote for the complete episode of care.
Who can use it: Check clinical suitability and payment arrangements with the provider.
Cost to you: varies — Confirm a written patient price or funding decision.
Reported public wait: No official figure available for this route.
- Ask for a full written price and exclusions.
- Confirm follow-up and how complications would be handled.
Compare private options below
Published waits are historical statistics, not an appointment forecast. Costs and waits are unknown unless a source is shown. Private comparisons below are in USD; official figures retain their source currency.